Advancements in Personalized Cellular Immunotherapy: A Comprehensive Guide to Cancer Treatment

Arun Kumar Singh, M. Pharm (Pharmaceutics) from Galgotias University, India, is an Assistant Professor at Amity Institute of Pharmacy, Amity University, India. His research interests include biopolymers, nanoformulation, and the application of nanotechnology in cancer treatment. He has authored multiple book chapters and articles within the field of cancer therapy and related biomaterials.

Dr. Murali Yallapu is a tenured Associate Professor at the University of Texas Rio Grande Valley (UTRGV) in the Immunology and Microbiology Department. He is also a member of the South Texas Center of Excellence in Cancer Research. Dr. Yallapu has received extensive postdoctoral training in materials science, drug delivery, nanomedicine, and cancer biology from institutions such as Cleveland Clinic and University of Nebraska Medical Center. Before UTRGV, he was an Assistant Professor at the University of Tennessee Health Science Center. He serves on editorial boards for various journals and as an ad-hoc reviewer for the NIH and other funding agencies. Dr. Yallapu has published over 190 peer-reviewed article. His research focuses on developing nanomaterials for improved therapeutic potentials and cancer immunotherapy.

Dr.Ciniraj is presently working as an Associate Professor at Medical College Thiruvananthapuram, Kerala, India, one of the largest multispecialty tertiary care hospitals in southern India. He undertakes teaching courses in oncology for undergraduate and postgraduate students. As a permanent faculty member appointed by the government of Kerala State, he is actively involved in patient care, curriculum development, teaching and evaluation, and clinical research. He actively participates in national and international conferences and institutional research methodology workshops. Currently, he undertakes research projects in clinical oncology at multiple government institutions as primary investigator. He also works as a guide to postgraduate thesis and assists them in their research work. He has a deep interest in oncology research and has published a few original research articles in clinical oncology, which are indexed in Scopus and PubMed. He has reviewed over 100 medical articles for leading publishers, including Elsevier, Springer, and British Medical Journal

Dr. Pranav Kumar Prabhakar is currently working as a Professor and Deputy Director at Parul University, Gujarat, India. He is one of the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, and 2024). He has completed his PhD in Biotechnology from IIT Madras. His main area of research interest focuses on elucidating molecular Mechanisms and Strategies for Oral Insulin Delivery, Mimicking the signaling pathways in Metabolic Disorders (diabetes) with Natural Products. He is a member of the Royal Society of Chemistry, and the Asia-Pacific Chemical, Biological& Environmental Engineering Society. He is also serving as an editorial board member and reviewer for many reputed national and International Journals. Dr. Pranav received honors including the recipient of a travel grant towards attending ATTD 2009 in Greece from the Indian Institute of Technology Madras & Council for Scientific and Industrial Research (CSIR) and approved by the Department of Science and Technology (DST). He has published 100+ research articles in journals, authored 8 books, and 25 book chapters. He also delivered 9 oral and poster presentations in scientific meetings.